News Industry News First Five Patients Successfully Treated with atHeart Medical's Novel reSept™ Atrial Septal Defect Occluder in U.S. IDE Pivotal Trial July 14, 2021
News Industry News NobleStitch™ EL Receives Approval Of IDE To Conduct A Trial For Reduction Of Recurrent Ischemic Stroke September 05, 2019
News Industry News GORE® CARDIOFORM ASD Occluder Receives FDA Approval for the Treatment of Atrial Septal Defects June 04, 2019
News Industry News FDA Approves GORE® CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke April 04, 2018
News Industry News Long-Term Study Results Show That PFO Closure May Be Effective In Preventing Recurrent Cryptogenic Stroke, Particularly In Younger Patients October 15, 2015
News Industry News Occlutech obtains European CE Approval for its novel mVSD Device September 30, 2015
News Industry News FDA Approves GORE® Septal Occluder for Use in Gore REDUCE Clinical Study October 22, 2012
News Industry News First Patient Enrolled in GORE® Septal Occluder Clinical Study for Atrial Septal Defect October 19, 2012